tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Naureen Quibria, 11 are a BUY (91.67%), 1 are a HOLD (8.33%).
Analyst Naureen Quibria, currently employed at CAPITAL ONE,
Naureen Quibria’s has documented 22 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ONCT, Oncternal Therapeutics at 04-Apr-2023.
Analyst best performing recommendations are on ONCR (ONCORUS ).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$13
$10.55 (430.61%)
$14
16 days ago
(08-Nov-2024)
0/4 (0%)
$9.76 (301.23%)
Buy
$7
$4.55 (185.71%)
8 months 23 days ago
(01-Mar-2024)
0/4 (0%)
$4.09 (140.55%)
Buy
$5
$2.55 (104.08%)
$6
2 years 1 months 28 days ago
(27-Sep-2022)
1/3 (33.33%)
$3.45 (222.58%)
533
Buy
$25
$23.61 (1698.56%)
3 years 2 months 16 days ago
(09-Sep-2021)
0/1 (0%)
$18.01 (257.65%)
What Year was the first public recommendation made by Naureen Quibria?
